Cellectar Biosciences Inc. (NASDAQ: CLRB)
$0.2483
+0.0133 ( +3.46% ) 778.7K
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Market Data
Open
$0.2483
Previous close
$0.2350
Volume
778.7K
Market cap
$9.70M
Day range
$0.2310 - $0.2490
52 week range
$0.2240 - $4.4500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
nt | Quarterly Reports | 1 | Aug 14, 2024 |
8-k | 8K-related | 14 | Aug 13, 2024 |
8-k | 8K-related | 13 | Aug 09, 2024 |
8-k | 8K-related | 15 | Jul 23, 2024 |
8-k | 8K-related | 19 | Jul 22, 2024 |
8-k | 8K-related | 16 | Jul 11, 2024 |
8-k | 8K-related | 13 | Jun 25, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |